Journal Title：Inflammopharmacology

Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS). Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn's disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle. The journal has seven main interest areas:

-Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress states

-Rheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugs

-Gastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agents

-Neuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and pain

-Novel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDs

-Muscle-immune interactions during inflammation [...]

《炎癥藥理學(xué)》是國際基礎(chǔ)和臨床藥理學(xué)聯(lián)合會 (IUPHAR) 胃腸道分會和匈牙利實驗和臨床藥理學(xué)協(xié)會 (HECPS) 的官方出版物。《炎癥藥理學(xué)》發(fā)表有關(guān)炎癥及其藥理學(xué)控制各個方面的論文，重點比較 (a) 不同的炎癥狀態(tài)，以及 (b) 用于治療炎癥的藥物的作用、治療效果和安全性。炎癥類型的比較方面包括胃腸道疾病（例如潰瘍性結(jié)腸炎、克羅恩病）、寄生蟲病、藥物和環(huán)境因素影響的毒理學(xué)表現(xiàn)、關(guān)節(jié)炎以及損傷或衰老對骨骼肌的炎癥影響。該期刊有七個主要興趣領(lǐng)域：

-藥物-疾病相互作用 - 條件藥理學(xué) - 即病情（疾病或壓力狀態(tài)）影響抗炎藥物的治療反應(yīng)和副作用（不良反應(yīng)）。藥物-疾病和藥物-疾病相互作用的機制以及不同應(yīng)激狀態(tài)的作用

-風(fēng)濕病學(xué) - 特別強調(diào)新藥物臨床反應(yīng)效果的測量方法、抗風(fēng)濕藥物的不良反應(yīng)

-胃腸病學(xué) - 特別強調(diào)動物和人類模型、粘膜炎癥和潰瘍的機制以及新型和已建立的抗?jié)儭⒖寡姿幬锘蚩辜纳x藥物的作用

-神經(jīng)炎癥和疼痛 - 模型系統(tǒng)、新型鎮(zhèn)痛劑的藥理學(xué)以及神經(jīng)炎癥和疼痛的機制

-新藥、天然產(chǎn)物和營養(yǎng)保健品 - 及其對炎癥過程的影響，特別是與傳統(tǒng)藥物（如 NSAID）相比有新作用模式的跡象

-炎癥期間的肌肉-免疫相互作用 [...]

Inflammopharmacology創(chuàng)刊于1991年，由Springer International Publishing出版商出版，收稿方向涵蓋IMMUNOLOGYTOXICOLOGY - TOXICOLOGY全領(lǐng)域，此刊是該細(xì)分領(lǐng)域中屬于非常不錯的SCI期刊，在行業(yè)細(xì)分領(lǐng)域中學(xué)術(shù)影響力較大，專業(yè)度認(rèn)可很高，所以對原創(chuàng)文章要求創(chuàng)新性較高，如果您的文章質(zhì)量很高，可以嘗試。平均審稿速度 ，影響因子指數(shù)4.6，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學(xué)者值得一試。